Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06345469

Cost Analysis of Therapies for Severe Anemia

Sponsor: Helios Klinik Gotha/Ohrdruf

View on ClinicalTrials.gov

Summary

The goal of this observational study is to learn about the costs that occur when participants with severe anemia are treated with blood transfusions or with patient blood management (PBM). PBM means that the body of the participant is stimulated to produce new blood by itself rather than receiving it from a blood donor, and to reduce blood losses. The main question the study aims to answer is: Do participants treated with transfusions incur the same treatment costs than participants treated with PBM? And how much costs are this in relation to the lives saved by the therapy of severe anemia?

Official title: Cost Effectiveness Analysis of Transfusion Therapy and Patient Blood Management in Patients With Severe Anemia

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

640

Start Date

2024-04-01

Completion Date

2026-05-01

Last Updated

2024-04-03

Healthy Volunteers

No

Conditions

Interventions

OTHER

Patient blood management (PBM)

PBM means the medical enhancement of the participants own hematopoietic reserve to treat anemia and to reduce the ill effects of disease and bleeding on hematopoiesis and homeostasis.

BIOLOGICAL

Allogeneic transfusion

transfusion of donor red cells